MoonLake Immunotherapeutics MLTX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's operating lease right-of-use assets in other assets?
- MoonLake Immunotherapeutics (MLTX) reported operating lease right-of-use assets in other assets of $1.86M in Q1 2026.
- How has MoonLake Immunotherapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- MoonLake Immunotherapeutics's operating lease right-of-use assets in other assets decreased by 28.3% year-over-year, from $2.59M to $1.86M.